Jump to content
This site uses cookies. Continued use is acceptance of our Terms of Use and Privacy Policy. More Info... ×
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.




  • Celiac.com Sponsor (A1):



    Celiac.com Sponsor (A1-M):


  • Get Celiac.com Updates:
    Support Our Content
    eNewsletter
    Donate
  • Jefferson Adams
    Jefferson Adams

    FDA Urges Transition to Disposable Duodenoscopes

    Reviewed and edited by a celiac disease expert.

    Post-market surveillance studies ordered by the FDA reveal that contamination rates for reusable duodenoscopes remain unacceptably high after reprocessing.

    FDA Urges Transition to Disposable Duodenoscopes - Image: CC BY-SA 4.0--Manu5
    Caption: Image: CC BY-SA 4.0--Manu5

    Celiac.com 09/10/2019 - The US Food and Drug Administration (FDA) is recommending that manufacturers of duodenoscopes, along with health care facilities, switch to duodenoscopes with disposable parts to help reduce the risk of patient infection.

    Post-market surveillance studies ordered by the FDA reveal that contamination rates for reusable duodenoscopes remain unacceptably high after reprocessing, with avoidable deaths and infections still occurring.

    Celiac.com Sponsor (A12):
    As a result, the agency is now recommending the elimination of duodenoscopes with fixed endcaps in favor of those with either disposable components, including disposable endcaps, or fully disposable duodenoscopes as they become available.

    By simplifying or eliminating the need for reprocessing, disposable duodenoscopes may reduce between-patient contamination associated with reusable, or fixed endcaps, says an agency communication.

    Duodenoscope Transition Will Be Gradual

    The FDA is urging that the transition to disposable duodenoscopes, or those with disposable parts, be undertaken gradually, as full-market withdrawal of conventional, fixed endcap duodenoscopes is unfeasible, and could trigger a shortage. 

    "We recognize that a full transition away from conventional duodenoscopes to innovative models will take time and immediate transition is not possible for all health care facilities due to cost and market availability," Jeff Shuren, MD, director of the FDA's Center for Devices and Radiological Health, said in the release.

    Though a slow transition may seem less optimal, "the FDA believes, at this time, the continued availability of these devices is in the best interest of the public health," the agency said.

    The FDA is working with manufacturers to increase the supply of disposable cap duodenoscopes and develop new device designs that will further reduce or eliminate the risk of patient infection, Shuren said.

    Specifically, the FDA is recommending healthcare facilities transition away from fixed endcap models, including Olympus Corporation's TJF-Q160, TJF-Q180V, PJF-160, and JF-140F; Fujifilm Medical Systems USA's ED-530XT; and Pentax Medical's ED-3490TK.

    Read more at Medscape Medical News



    User Feedback

    Recommended Comments

    Awol cast iron stomach

    It does seem like a good idea for public health and safety.

    Link to comment
    Share on other sites
    sc'Que?

    I would transition away from disposable everything... and figure out a way to BETTER STERILIZE EQUIPMENT like they did in years past--autoclave, anyone?  Too much plastic, not enough reusable materials in the medical industry! 

    Link to comment
    Share on other sites


    Create an account or sign in to comment

    You need to be a member in order to leave a comment

    Create an account

    Sign up for a new account in our community. It's easy!

    Register a new account

    Sign in

    Already have an account? Sign in here.

    Sign In Now

  • Get Celiac.com Updates:
    Support Celiac.com:
    Donate
  • About Me

    Jefferson Adams

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University. His articles, essays, poems, stories and book reviews have appeared in numerous magazines, journals, and websites, including North American Project, Antioch Review, Caliban, Mississippi Review, Slate, and more. He is the author of more than 2,500 articles on celiac disease. His university coursework includes studies in science, scientific methodology, biology, anatomy, physiology, medicine, logic, and advanced research. He previously devised health and medical content for Colgate, Dove, Pfizer, Sharecare, Walgreens, and more. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of numerous books, including "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

    >VIEW ALL ARTICLES BY JEFFERSON ADAMS

     


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Related Articles

    Jefferson Adams
    FDA Clarifies Gluten-Free Rules for Restaurants
    Celiac.com 01/03/2014 - The United State Food and Drug Administration (FDA) has clarified what their recent gluten-free rule means for restaurants. When the FDA announced its gluten-free labeling standard in August, the agency said that, for restaurants, “any use of an FDA-defined food labeling claim (such as “fat free” or “low cholesterol”) on restaurant menus should be consistent with the respective regulatory definitions.
    The agency noted this same approach would now be followed with respect to “gluten-free” claims made in restaurants and other retail food service establishments.
    The FDA's updated Open Original Shared Link, #9 under ‘Labeling’, now reads:
    FDA recognizes that compliance with the gluten-free rule in processed foods and food served in restaurants is important for ...


    Jefferson Adams
    Duodenoscopes Often Contaminated with Dangerous Bacteria After Reprocessing
    Celiac.com 12/26/2018 - The first wave of results are in from the 2015 FDA-mandated post-market surveillance studies of duodenoscopes, and they are not encouraging. The duodenoscopes are designed to be reprocessed, to be cleaned and disinfected, according to manufacturer guidelines. However, reprocessed scopes show "higher-than-expected" rates of contamination with dangerous bacteria.
    In a recent safety announcement, the FDA revealed that 3% of properly collected samples tested positive for more than 100 colony-forming units of "low-concern" organisms. These bacteria are not likely to cause serious infections, but they do indicate "reprocessing failure."
    Moreover, an additional 3% of properly collected samples tested positive for "high-concern" bacteria that are more often...


    Jefferson Adams
    FDA Warns of Deadly Duodenoscope Contamination Rates
    Celiac.com 06/03/2019 - In 2015, the FDA ordered duodenoscope makers Olympus, Fujifilm, and Pentax to conduct post-market surveillance studies to determine how infections were being transmitted, and to assess the factors that may be contributing to the problem. Interim results from those FDA–mandated studies show unacceptably high contamination rates after reprocessing, with deaths and infections as a result, the FDA said today.
    The agency said three deaths in the United States in 2018 were likely due to contaminated duodenoscopes. "That's three deaths too many," Jeff Shuren, MD, director of the Center for Devices and Radiological Health, said in a statement.
    The problem first surfaced in 2013, when the FDA became aware that reprocessed duodenoscopes were transmitting multidrug-re...


    Jefferson Adams
    FDA Approves New Test for Celiac Disease
    Celiac.com 07/18/2019 - Autoimmune conditions cause the body to attack its own healthy cells. There are nearly one-hundred known autoimmune conditions, including lupus, celiac disease, and rheumatoid arthritis.
    Diagnosing autoimmune conditions can sometimes be difficult, so any progress toward faster, cheaper, or more reliable testing methods could play a significant role in improving diagnosis and reducing time to treatment. Approval by the FDA is key to making such tests available commercially.
    A New York startup company, Aesku.NY, has received FDA approval for tests to detect two of those autoimmune diseases, with tests for other diseases expected to follow. 
    The approved tests for celiac disease, and the connective tissue disorder, lupus, would still require patients ...


  • Recent Activity

    1. - knitty kitty replied to BoiseNic's topic in Dermatitis Herpetiformis
      1

      Skinesa

    2. - Wheatwacked replied to Celiacsugh's topic in Post Diagnosis, Recovery & Treatment of Celiac Disease
      6

      gluten-free and continued upper left side pain after drinking wine

    3. - trents replied to Celiacsugh's topic in Post Diagnosis, Recovery & Treatment of Celiac Disease
      6

      gluten-free and continued upper left side pain after drinking wine

    4. - Celiacsugh replied to Celiacsugh's topic in Post Diagnosis, Recovery & Treatment of Celiac Disease
      6

      gluten-free and continued upper left side pain after drinking wine

    5. - trents replied to Celiacsugh's topic in Post Diagnosis, Recovery & Treatment of Celiac Disease
      6

      gluten-free and continued upper left side pain after drinking wine


  • Celiac.com Sponsor (A19):



  • Member Statistics

    • Total Members
      126,266
    • Most Online (within 30 mins)
      7,748

    Toni Martine
    Newest Member
    Toni Martine
    Joined

  • Celiac.com Sponsor (A20):


  • Forum Statistics

    • Total Topics
      120.9k
    • Total Posts
      69.3k

  • Celiac.com Sponsor (A22):




  • Who's Online (See full list)


  • Celiac.com Sponsor (A21):



  • Popular Now

    • Celiacsugh
    • llisa
      20
    • More2Learn
      9
  • Popular Articles

    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
  • Upcoming Events

×
×
  • Create New...